We refer to the Company’s earlier announcements in relation to the proposed selective capital reduction and repayment exercise of AMPROP pursuant to Section 116 of the Companies Act 2016 (“Proposed SCR”).

As announced on 28 May 2021, the non-interested Directors of the Company had resolved not to grant any further options under the ESS and to terminate the ESS after approval has been obtained from the non-interested shareholders of AMPROP for the Proposed SCR. Subsequently, the Company had obtained its non-interested shareholders’ approval for the Proposed SCR at its extraordinary general meeting held on 5 August 2021.

In view of the above, the Board of Directors of AMPROP wishes to announce that the Company’s ESS was terminated on 19 August 2021 (“Termination Date”), in accordance with the provisions of the by-laws governing the ESS.

Since the implementation of the ESS on 18 September 2012, a total of 93,002,312 options have been exercised. A total of 49,354 granted options remained unexercised as at the Termination Date, all of which shall be deemed to have been cancelled and be null and void upon termination of the ESS.

This announcement is dated 19 August 2021.